DNA damage repair defects as a new class of endocrine treatment resistance driver
Oncotarget
.
2018 Nov 20;9(91):36252-36253.
doi: 10.18632/oncotarget.26363.
Authors
Meenakshi Anurag
1
,
Matthew J Ellis
1
,
Svasti Haricharan
1
Affiliation
1
Svasti Haricharan: Department of Tumor Microenvironment and Cancer Immunology, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
PMID:
30555626
PMCID:
PMC6284739
DOI:
10.18632/oncotarget.26363
No abstract available
Keywords:
DNA repair; endocrine treatment resistance.
Publication types
Editorial
Grants and funding
K22 CA229613/CA/NCI NIH HHS/United States